How much will the out-of-pocket cost of Eltrombopag be after medical insurance in 2023?

Eltrombopag/Eltrombopag (Eltrombopag) is a thrombopoietin receptor agonist used to treat thrombocytopenia. It promotes the production, maturation and release of platelets by stimulating stem cells and precursor cells in the bone marrow, thereby increasing the number of platelets and improving coagulation function.

Eltrombopag/Eltrombopag has been launched in China and is included in medical insurance. Because medical insurance policies vary from place to place, the price after reimbursement is also different. For details, please consult the local hospital pharmacy or medical insurance bureau. Please consult the hospital pharmacy for specific self-payment after medical insurance.

OverseasEltrombopag/Eltrombopag has original drugs and generic drugs. The original drugs include the Turkish original drug and the Indian version of the original drug. The prices of the two are almost the same, about more than a thousand yuan. There are many versions of generic drugs, including those from India, Bangladesh, and Laos. The cheaper generic drug is Eltrombopag from Everest Pharmaceuticals in Bangladesh, which costs around a few hundred yuan. Other generic drugs are around one to two thousand yuan, and the ingredients of the original drug and the generic drug are basically the same.

Eltrombopag/Eltrombopag is mainly used for idiopathic thrombocytopenic purpura (ITP). ITP is an immune disease in which the immune system attacks the patient's own platelets, resulting in low platelets and increased risk of bleeding. Eltrombopag/EltrombopagReduces bleeding symptoms by increasing the number of platelets. Also includes Chronic liver disease-related thrombocytopenia. Some patients with chronic liver disease may experience thrombocytopenia due to impaired liver function. Eltrombopag/Eltrombopag can increase platelet count and reduce the risk of bleeding.

Eltrombopag/Eltrombopag and thrombopoietin receptor (TPOreceptor), simulating the effects of thrombopoietin. This stimulates stem and precursor cells in the bone marrow, promoting the formation and release of platelets. Through this mechanism, Eltrombopag/Eltrombopag increases the number of platelets and helps restore normal coagulation function.